Complement-dependent acceleration of apoptosis in neutrophils by dialyzer membranes. 2001

A R Rosenkranz, and E Peherstorfer, and G F Körmöczi, and G J Zlabinger, and G Mayer, and W H Hörl, and R Oberbauer
Leopold Franzens Universität Innsbruck, Universitätsklinik für Innere Medizin, Klinische Abteilung für Nephrologie, Innsbruck, Austria. alexander.rosenkranz@uibk.ac.at

Recently, we have shown that cuprophan (CU) causes receptor modulation by a C5-dependent mechanism, which is activated by neutrophil-derived reactive oxygen intermediates. The objective of our study was to evaluate the contribution of dialyzer membranes to the induction of apoptosis in human neutrophils [polymorphonuclear cells (PMNs)]. PMNs harvested from healthy donors were incubated with hollow fibers from a biocompatible membrane polysulfone (PS) and a bioincompatible membrane CU, all in the presence of 25% human serum. After 4, 8, and 12 hours of incubation at 37 degrees C, apoptosis was quantitated by counting the numbers of cells showing features of apoptosis on cytospins by light microscopy and also by flow cytometry using propidium iodide nuclear staining. Compared with PMNs incubated with serum alone, cells cultured with fibers of PS demonstrated a higher percentage of apoptosis. Fibers from CU dialyzers led to a more pronounced induction of apoptosis in PMNs, which was significantly higher compared with PS. This effect was partly mediated by heat-sensitive serum products and depended on the presence of divalent cations. In contrast to the recently described C5-dependent pathway in PMN receptor modulation by CU, this effect seemed to depend on the presence of the complement factor C3. In conclusion, our results indicate that besides the well-known accelerated apoptosis of PMNs in uremia, both biocompatible and bioincompatible dialyzer material itself can accelerate apoptosis in human PMNs.

UI MeSH Term Description Entries
D007688 Kidneys, Artificial Devices which can substitute for normally functioning KIDNEYS in removing components from the blood by DIALYSIS that are normally eliminated in the URINE. Artificial Kidney,Kidney, Artificial,Artificial Kidneys,Blood Dialyser,Blood Dialyzers,Hemodialyser,Hemodialyzers,Renal Dialysis Machine,Blood Dialysers,Blood Dialyzer,Dialyser, Blood,Dialysers, Blood,Dialysis Machine, Renal,Dialysis Machines, Renal,Dialyzer, Blood,Dialyzers, Blood,Hemodialysers,Hemodialyzer,Machine, Renal Dialysis,Machines, Renal Dialysis,Renal Dialysis Machines
D008567 Membranes, Artificial Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION. Artificial Membranes,Artificial Membrane,Membrane, Artificial
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D002482 Cellulose A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations. Alphacel,Avicel,Heweten,Polyanhydroglucuronic Acid,Rayophane,Sulfite Cellulose,alpha-Cellulose,Acid, Polyanhydroglucuronic,alpha Cellulose
D002614 Chelating Agents Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. Chelating Agent,Chelator,Complexons,Metal Antagonists,Chelators,Metal Chelating Agents,Agent, Chelating,Agents, Chelating,Agents, Metal Chelating,Antagonists, Metal,Chelating Agents, Metal
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013450 Sulfones Sulfone

Related Publications

A R Rosenkranz, and E Peherstorfer, and G F Körmöczi, and G J Zlabinger, and G Mayer, and W H Hörl, and R Oberbauer
August 1986, Artificial organs,
A R Rosenkranz, and E Peherstorfer, and G F Körmöczi, and G J Zlabinger, and G Mayer, and W H Hörl, and R Oberbauer
January 1986, ASAIO transactions,
A R Rosenkranz, and E Peherstorfer, and G F Körmöczi, and G J Zlabinger, and G Mayer, and W H Hörl, and R Oberbauer
December 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
A R Rosenkranz, and E Peherstorfer, and G F Körmöczi, and G J Zlabinger, and G Mayer, and W H Hörl, and R Oberbauer
January 1999, Journal of the American Society of Nephrology : JASN,
A R Rosenkranz, and E Peherstorfer, and G F Körmöczi, and G J Zlabinger, and G Mayer, and W H Hörl, and R Oberbauer
May 1977, The Journal of clinical investigation,
A R Rosenkranz, and E Peherstorfer, and G F Körmöczi, and G J Zlabinger, and G Mayer, and W H Hörl, and R Oberbauer
January 1991, Advances in experimental medicine and biology,
A R Rosenkranz, and E Peherstorfer, and G F Körmöczi, and G J Zlabinger, and G Mayer, and W H Hörl, and R Oberbauer
January 1989, ASAIO transactions,
A R Rosenkranz, and E Peherstorfer, and G F Körmöczi, and G J Zlabinger, and G Mayer, and W H Hörl, and R Oberbauer
January 1988, ASAIO transactions,
A R Rosenkranz, and E Peherstorfer, and G F Körmöczi, and G J Zlabinger, and G Mayer, and W H Hörl, and R Oberbauer
January 1990, Biomaterials, artificial cells, and artificial organs,
A R Rosenkranz, and E Peherstorfer, and G F Körmöczi, and G J Zlabinger, and G Mayer, and W H Hörl, and R Oberbauer
December 1991, Kidney international,
Copied contents to your clipboard!